Penn Medicine Provider
Medical Oncology
Hayley M. Knollman, MD
5.0
(622)
Accepting new patients
Sees patients age 18 and up
Rena Rowan Breast Center

About me

  • Physician Leader, Oncology Clinical Effectiveness Team
  • Assistant Professor of Clinical Medicine (Hematology-Oncology)

Education and training

  • Medical School: Indiana University School of Medicine
  • Residency: Barnes-Jewish Hospital - Washington University, St. Louis
  • Fellowship: Temple University Hospital

What my patients think about me

Average Rating
5.0

622 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
excellent bedside manner
May 2025
5.0
5.0
i have already told anyone who needs an oncologist to see her. she is the best!
May 2025
5.0
5.0
the doctor not only provided excellent care she was caring, kind and compassionate.
May 2025
5.0
5.0
she was very informative and explain things straight to understand

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Knollman is a Penn Medicine physician.

Qualifications and experience

My research

Julia Tchou, Amy Clark, Neil Taunk, Gary Freedman, Nucleus Xu, Andy Minn, Angela Bradbury, Angela Demichele Gross, Susan Domchek, Hayley Knollman, Rachel Jankowitz, Payal Shah, Oluwadamilola Fayanju, Anupma Nayak, Joseph Fraietta and Alexander Huang Major pathologic response after a single radiotherapy fraction + a single pembrolizumab dose given preoperatively in patients with cT1N0 triple negative breast cancer (TNBC) – preliminary results of a phase 1b/2 study (NCT04454528) , Journal for ImmunoTherapy of Cancer, Society for Immunotherapy of Cancer, Denver, CO, 10: 2023,A674-A674


Alexandra Torres; Carey Kokkonen; Mary Oladeji; Kurt D'Andrea; Rosemarie Mick; Vivek Narayan; Michael Mallamaci; Gayle Ewing; Hayley Knollman; Nadine M. Tung; Mark Robson; Katherine L. Nathanson; Susan Domchek; Payal D. Shah Harnessing olaparib, palbociclib, and endocrine therapy (HOPE): Phase I/II trial of olaparib, palbociclib and fulvestrant in patients with BRCA1/2-associated, hormone receptor-positive, HER2-negative metastatic breast cancer , San Antonio Breast Cancer Symposium, San Antonio, TX., 82: 2022


Lauren Bayne; Isoris Nivar; Brooke Goodspeed; Shannon Deluca; E. Paul Wileyto; Natalie Shih; Anupma Nayak; Michael D Feldman; Joshua Edwards; Kevin Fox; Jennifer M. Matro; Susan Domchek; Hayley Knollman; Rachel Jankowitz; Angela Bradbury; Payal D. Shah; Jewell Graves; George Woodfield; Elizabeth Chislock; Jianping Wang; George Belka; Lewis A. Chodosh; Amy S. Clark; Angela DeMichele Identifying breast cancer survivors with dormant disseminated tumor cells: The PENN-SURMOUNT screening study , Cancer Research, San Antonio Breast Cancer Symposium, San Antonio, TX. , 81: 2021


Igor Makhlin; Amy S Clark; Paul Wileyto; Noah Goodman; John Ndicu; Shannon DeLuca; Candace Clark; S. William Stavropoulos; Natalie Shih; Michael D Feldman; Susan M Domchek; Jennifer M Matro; Payal D Shah; Hayley M Knollman; Kevin R Fox; Kara N Maxwell; Lewis A Chodosh; Angela DeMichele Investigating the clinical utility of tumor mutational burden in predicting rapid progression and death in patients with metastatic breast cancer , Cancer Research/San Antonio Breast Cancer Symposium, San Antonio, TX., 81: 2021


Biniyam G.Demissei, Srinath Adusumalli, Rebecca A.Hubbard, Srinivas Denduluri, Vivek Narayan, Amy S. Clark, Payal Shah, Hayley Knollman, Kelly D. Getz, Richard Aplenc, Joseph R. Carver, Bonnie Ky Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab , JACC CardioOncology, 2(2): 2020,179-189


Biniyam G. Demissei, Rebecca A. Hubbard, Liyong Zhang, Amanda M. Smith, Karyn Sheline, Caitlin McDonald, Vivek Narayan, Susan M. Domchek, Angela DeMichele, Payal Shah, Amy S. Clark, Kevin Fox, Jennifer Matro, Angela R. Bradbury, Hayley Knollman, Kelly D. Getz, Saro H. Armenian, James L. Januzzi, W. H. Wilson Tang, Peter Liu, and Bonnie Ky Changes in Cardiovascular Biomarkers with Breast Cancer Therapy and Associations with Cardiac Dysfunction , Journal of the American Heart Association, 9(2): 2020,e014708.


West AH1, 2, Knollman H3, Dugan J4, Hedeker D5, Handorf EA6, Nielsen SM1, 2, Bealin LC3, Goldblatt LG3, Willems H4, Daly MB3, Afghahi A4, Olopade OI1, 2, Hulick PJ7, Shagisultanova E4, Huo D1, 5, Obeid E3, Churpek JE1, 2. Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study , Cancer Medicine, 8(12): 2019,5609-5618


ES McDonald; S Carlin; KN Maxwell; A Nayak; RK Doot; AR Pantel; MD Farwell; DA Pryma; AS Clark; P Shah; AM DeMichele; A Ziober; EK Schubert; K Palmer; HS Lee; J Matro; L de la Cruz; J Tchou; DN Anderson; MD Feldman; RE Sheffer; H Knollman; MD Schnall; M Makvandi; S Domchek; RA Hubbard; RH Mach; DA Mankoff PET imaging of PARP-1 expression in breast cancer , Cancer Research, 79: 2019


Knollman H, Godwin JL, Jain R, Wong YN, Plimack ER, Geynisman DM. Muscle-invasive urothelial bladder cancer: an update on systemic therapy. , Ther Adv Urol, 7(6): 2015,312-30


Abonour R, Knollman H, Suvannasankha A, Menggang Y, Britton R, Srivastava S, Nelson RP, Schwartz JE, Robertson M, Cornetta K, Farag S. Infusion of large number of circulating myeloma cells does not influence the survival of patience undergoing autologous stem cell transplantation. , Presented at the American Society of Hematology Meeting, New Orleans, LA: 2009